Inozyme Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Inozyme Pharma and buy or sell other stocks, ETFs, and their options commission-free!About INZY
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton.
CEODoug Treco Treco, PhD
CEODoug Treco Treco, PhD
Employees67
Employees67
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2015
Founded2015
Employees67
Employees67
INZY Key Statistics
Market cap257.88M
Market cap257.88M
Price-Earnings ratio-2.38
Price-Earnings ratio-2.38
Dividend yield—
Dividend yield—
Average volume712.81K
Average volume712.81K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.24
52 Week high$6.24
52 Week low$0.721
52 Week low$0.721
Stock Snapshot
With a market cap of 257.88M, Inozyme Pharma(INZY) trades at $4.00. The stock has a price-to-earnings ratio of -2.38.
Inozyme Pharma(INZY) stock opened on 2025-11-27 at —. The price climbed to — and dipped to —.
The Inozyme Pharma(INZY)'s current trading volume is 0, compared to an average daily volume of 712.81K.
During the past year, Inozyme Pharma(INZY) stock moved between $0.72 at its lowest and $6.24 at its peak.
During the past year, Inozyme Pharma(INZY) stock moved between $0.72 at its lowest and $6.24 at its peak.
People also own
Based on the portfolios of people who own INZY. This list is generated using Robinhood data, and it’s not a recommendation.